Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG effects on yellow fever vaccination immunity
NL-OMON40902Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Feb 2015
- Modality
- Vaccines & Immunotherapeutics, Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Randomised, double-blind trial of bcg vaccine, 17D yellow fever vaccine and Placebo-COD Research Private Ltd in yellow fever, Tuberculosis (TB) and leprosy (HD) (2 arms), sponsored by Radboud University Medical Center. Primary endpoints: Increase in in vitro cytokine production after yellow fever vaccination, Yellow fever antibody and cellular immune responses and 1 more. Started Feb 2015; status: active, not recruiting.
02
Drugs
bcg vaccine17D yellow fever vaccinePlacebo-COD Research Private Ltd
03
Conditions
yellow feverTuberculosis (TB)leprosy (HD)
Beyond the preview
Go deeper on NL-OMON40902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40902.